Mutation Carrier Screening
Sponsors
Lawrence Livermore National Laboratory at University of California, Leeds Cancer Centre at St. James's University Hospital, National Cancer Institute (NCI), Ohio State University Comprehensive Cancer Center
Conditions
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia, Myelodysplasia-RelatedAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Ann Arbor Stage III Non-Hodgkin Lymphoma
Phase 2
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men
NCT00354497
Start: 2002-03-31Target: 800Updated: 2013-09-20
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Active, not recruitingNCT03155620
Start: 2017-07-31End: 2027-01-06Updated: 2026-02-10
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingNCT05564390
Start: 2024-06-18End: 2029-05-15Target: 2000Updated: 2026-04-03
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingNCT05564377
Start: 2023-04-07End: 2030-07-01Target: 2900Updated: 2026-04-03
Unknown Phase
Study of Families With Melanoma
NCT00445783
Start: 2000-07-31Target: 3700Updated: 2013-08-12
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593
Start: 1989-01-31Target: 5000Updated: 2013-08-12
Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care
CompletedNCT03460483
Start: 2018-03-30End: 2025-06-15Updated: 2025-10-03